Status: current, Defined. Date: 31-Oct 2019. Module: SNOMED Clinical Terms Australian extension
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4215551000168112 | Measurement of adalimumab in serum specimen (procedure) | en | Fully specified name | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| 4215561000168114 | Measurement of adalimumab in serum specimen | en | Synonym | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| 4215571000168115 | Serum adalimumab measurement | en | Synonym | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| 4215581000168117 | Serum adalimumab level | en | Synonym | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Serum adalimumab measurement | Is a | Protein measurement | true | Inferred relationship | Some | ||
| Serum adalimumab measurement | Has specimen | Serum specimen | true | Inferred relationship | Some | 771470021 | |
| Serum adalimumab measurement | Component | Adalimumab | true | Inferred relationship | Some | 771470021 | |
| Serum adalimumab measurement | Method | Measurement - action | true | Inferred relationship | Some | 771470021 | |
| Serum adalimumab measurement | Is a | Measurement of level of substance in blood | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Procedure foundation reference set
FHIR